Renee Masi

Renee Masi currently serves as a Managing Director at BioStar Ventures, a venture capital firm focused on early-stage investments within the biotechnology and life sciences sectors. In her capacity as a key leader at the firm, she directs capital allocation strategies targeting emerging medical technologies. Her investment mandate centers on identifying early-stage enterprises that are developing novel solutions to address unmet clinical needs across the healthcare industry. Operating within the capital-intensive life sciences ecosystem, Masi evaluates prospective portfolio additions based on scientific viability and potential paths to commercialization. As a senior venture capital professional, she plays an integral role in structuring financing rounds and guiding the strategic direction of the firm's investment vehicles. Masi maintains a dedicated focus on advancing early-stage biotechnology ventures through the complex developmental phases required to reach the commercial market.